About
Moletest (Scotland) Limited is the developer of nomela® a definitive 'rule-out' test for melanoma. We are an innovative independent British company dedicated to advancing melanoma screening and improving the patient pathway in dermatology care. The multidisciplinary team of experts at the heart of the company developed the technology that powers its melanoma screening test. This research has evolved into various forms of machine vision and signal analysis to ensure safe, robust and consistent performance. The end result is nomela®, a definitive ‘rule-out' medical device for suspected melanoma. Learn more: https://nomela.com/
Technologies
Route 53GmailGoogle AppsLinkedin Marketing SolutionsSquarespace ECommerceMobile FriendlyTypekitGoogle Tag ManagerGoogle AnalyticsRemoteAI
Keywords
backlogcancer screeningpatient referral system optimisationmelanoma screeningdigital healthskin cancer screeninghealth technhs digitalmedical devicedermatology image processingrisk assessmentai in dermatologysecure data transmissiondeep learningai for pigmented lesionssecure healthcare it integrationdermatology ai systemrisk assessment for melanomamedical device softwaredermatologyclinical screening supportautomated edge detectionon-device ai analysison-device machine learning aihealthcare cybersecuritymelanoma risk assessmentai diagnostic accuracyai edge detection technologymedical equipment and supplies manufacturingclinical screening aid
Company Information
- Employees2
- Founded2014
Location
Conference Square, Edinburgh, Scotland, United Kingdom, EH3 8
